title: Intravenous low-dose iron administration in hemodialysis patients treated with erythropoietin: 1-year follow-up study.
authors.forename: I
authors.initials: I
authors.lastname: Kurihara
authors.forename: J
authors.initials: J
authors.lastname: Soma
authors.forename: K
authors.initials: K
authors.lastname: Nakayama
authors.forename: H
authors.initials: H
authors.lastname: Sato
authors.forename: T
authors.initials: T
authors.lastname: Saito
mesh_terms: D015415:Biomarkers / Q000097:blood; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D005293:Ferritins / Q000097:blood; D005500:Follow-Up Studies; D006400:Hematocrit; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D006435:Renal Dialysis; D013997:Time Factors
chemical_list: D015415:Biomarkers; D005290:Ferric Compounds; D011994:Recombinant Proteins; D004921:Erythropoietin; C000499:ferric oxide; D005293:Ferritins; D007501:Iron